Menu
  • Home
  • Upcoming Events
  • Industry Opportunities
  • Mentorship Program
  • Newsletter
    • Biotech Breakthroughs
      • SARS-CoV-2 Treatment and Vaccines
      • A Self-Orienting Device for Oral Delivery of Biomacromolecules
      • Synergistic ICB and Neoantigen Vaccine
      • Nanopore Protein Sequencing
    • Company Spotlights
      • Taysha Gene Therapies
      • Abbvie Inc.
      • Kaleido Biosciences
      • Gilead Sciences, Inc
      • Vertex Pharmaceuticals
      • Reata Pharmaceuticals
    • Industry Scientist Interviews
      • Biotech Career Roundtable 03/23/2021
      • Biotech Career Roundtable 11/18/20
      • Kristen Hege
      • Jonathan Rosenblum
      • Lucy Shapiro
      • Christian Cunningham
      • Kathy Brendza
      • John Butler
    • Biotech Market Trends
      • DNA Market
      • Cost Effectiveness of Drugs: Is ICER enough?
      • Checkpoint Inhibitor Market
      • The CRISPR Boom
      • Alzheimer's Detection and Treatment
      • RNAi
      • Microbiome Market
      • Chronic Kidney Disease
  • Our team
  • Contact
More

Company Spotlights

Gilead Sciences, Inc.

Gilead Sciences is a California-based biotechnology company focused on antiviral drug development. 

Vertex Pharmaceuticals

Vertex is a young biotechnology company undertaking rational drug design in rare diseases like cystic fibrosis headquartered in Boston, Massachusetts. 

Reata Pharmaceuticals

Reata Pharmaceuticals is a rising Dallas pharmaceutical company undertaking drug design for rare diseases caused by mitochondrial dysfunction.

AbbVie, Inc.

AbbVie, Inc. is a biopharmaceutical company tackling a variety of chronic and life-threatening illnesses.

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage biotechnology company based in Bedford, MA focusing on microbiome-therapeutics.

Taysha Gene Therapies

Taysha Gene Therapies is a UTSW spin-out company founded in 2019 partnered with the world class UTSW Gene Therapy Program. Taysha looks to tackle a variety of monogenic central nervous system (CNS) diseases through advancing a deep pipeline of gene therapies in patients with unmet medical needs.

UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-5525
Powered by Webnode